Home / STOCK / Tesla stock poised for weekly gain as Musk prepares to make full return to company amid alleged drug abuse

Tesla stock poised for weekly gain as Musk prepares to make full return to company amid alleged drug abuse

Tesla stock poised for weekly gain as Musk prepares to make full return to company amid alleged drug abuse
Tesla stock poised for weekly gain as Musk prepares to make full return to company amid alleged drug abuse


Tesla stock (TSLA) is poised for a notable weekly gain, capping off an eventful week for the electric vehicle manufacturer and its CEO, Elon Musk. After a period of speculation regarding his commitment to Tesla, Musk is preparing to refocus his efforts back on the company as he steps down from his government role. This shift follows a New York Times report detailing Musk’s alleged substance abuse, raising concerns and questions about his well-being and leadership.

According to the report, Musk’s use of both prescription medications and illegal drugs has reportedly been more intense than previously acknowledged. Sources indicate that while on the campaign trail for former President Trump, Musk maintained a medication box containing around 20 pills and was using ketamine—known for its hallucinogenic effects—so frequently that it adversely affected his bladder health. Additionally, he allegedly experimented with other substances such as ecstasy, psychedelic mushrooms, and Adderall.

At a recent press conference marking his last day as a special government employee, Musk deflected questions about these serious allegations. Quoting the New York Times, he remarked, “That New York Times? Let’s move on,” further criticizing the publication’s past reporting on Trump and Russia.

Adding intrigue to the story was an apparent black eye that Musk appeared to sport during the conference. He attributed the injury to playful interaction with his son, stating, “I was horsing around with little X [Musk’s son], and I said ‘go ahead and punch me in the face,’ and he did.” While this explanation may seem lighthearted, the circumstances have ignited widespread discussions about Musk’s health and state of mind.

Despite these troubling revelations, Tesla’s stock remains bullish, showing signs of recovery and potential growth. Reports indicate that the stock is on track for a 20% increase for the month of May. Investors seem optimistic about Musk’s impending return to Tesla’s helm, especially amid the company’s ongoing developments. Earlier this week, he confirmed via X (formerly Twitter) that he would be leaving Washington, where he led the controversial Department of Government Efficiency (DOGE), and returning to focus on Tesla, SpaceX, and other projects. Musk emphasized the demand for his intense dedication to these endeavors, which includes significant upcoming developments in AI and space technology.

Musk’s recent communication hinted at a busy schedule ahead, as he remarked that he would be “spending 24/7 at work and sleeping in conference/server/factory rooms.” He alluded to a critical period of technological rollout for Tesla and the urgent need to focus on projects such as the Starship launch slated for next week.

In addition to addressing substance-related concerns, Musk is concentrated on Tesla’s imminent testing of robot taxis, with operations set to commence in Austin, Texas, on June 12. The company has been rigorously testing self-driving Model Y vehicles on public roads in Austin without incident, according to Musk. This move signifies a crucial step toward the future of autonomous driving technology, as Tesla aims to introduce its first dedicated robotaxi, the Cybercab, in 2026.

Moreover, Musk has revealed plans for Tesla’s inaugural “self-delivery” process, enhancing the overall customer experience. This initiative indicates Musk’s ambition to reshape how Tesla delivers its vehicles, fortifying the company’s commitment to technological innovation and self-sustainability.

As Tesla prepares for a new chapter under Musk’s direct supervision, the juxtaposition of his leadership and the controversies surrounding his personal life creates a potent narrative. While investors are optimistic about the strides Tesla is making in technology and vehicle performance, the underlying issues regarding Musk’s health and substance use warrant a closer examination. The weight of public scrutiny continues to hover over Musk, as he navigates his personal struggles and professional responsibilities.

In conclusion, Tesla’s outlook appears favorable as the company transitions back under the purview of its founder. Musk’s ambitious plans for technological advancements and innovative solutions in the automotive industry remain compelling. However, it is essential to consider the complex interplay of Musk’s personal challenges and his role as a leader. As the stock trends upward, all eyes remain on Musk—both in his professional journey and his personal growth. The coming weeks will be crucial in determining not just Tesla’s stock performance but also the sustainability of its vision and Musk’s role in guiding it forward.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *